Glaxo SmithKline
This article was originally published in The Tan Sheet
Executive Summary
EC approves proposed merger of Glaxo Wellcome and SmithKline Beecham provided the firms outlicense or divest certain Rx drugs in EU countries. FTC has not yet completed its review of the merger